Advertisement

Pulmonary Embolism

  • Hanna Z. Mieszczanska
  • Scott J. Cameron
Chapter

Abstract

Venous thromboembolism (VTE), which includes acute pulmonary embolism (PE) and deep vein thrombosis (DVT), is responsible for 250,000 annual hospitalizations in the United States and is a major cause of morbidity and mortality worldwide. Advancing age is the strongest risk factor for VTE prevalence. Acute PE is the most serious clinical presentation of VTE.

Keywords

Venous thromboembolism Acute pulmonary embolism Deep vein thrombosis Risk stratification Thrombolysis Anticoagulation 

References

  1. 1.
    Belohlavek J, Dytrych V, Linhart A. Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol. 2013;18(2):129–38.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Centers for Disease Control and Prevention. Venous Thromboembolism. 2017.https://www.cdc.gov/ncbddd/dvt/data.html.
  3. 3.
    Wolf SJ, et al. Prospective validation of wells criteria in the evaluation of patients with suspected pulmonary embolism. Ann Emerg Med. 2004;44(5):503–10.CrossRefPubMedGoogle Scholar
  4. 4.
    Investigators P. Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA. 1990;263(20):2753–9.CrossRefGoogle Scholar
  5. 5.
    Aujesky D, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041–6.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Dentali F, et al. Pulmonary embolism severity index accurately predicts long-term mortality rate in patients hospitalized for acute pulmonary embolism. J Thromb Haemost. 2013;11(12):2103–10.CrossRefPubMedGoogle Scholar
  7. 7.
    Meyer G, Vieillard-Baron A, Planquette B. Recent advances in the management of pulmonary embolism: focus on the critically ill patients. Ann Intensive Care. 2016;6(1):19.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Aujesky D, et al. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J. 2006;27(4):476–81.CrossRefPubMedGoogle Scholar
  9. 9.
    Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part II: risk stratification, treatment, and prevention. Circulation. 2003;108(23):2834–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Jaff MR, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–830.CrossRefPubMedGoogle Scholar
  11. 11.
    Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer. J Am Coll Cardiol. 2017;70(19):2411–20.CrossRefPubMedGoogle Scholar
  12. 12.
    Tapson VF. Acute pulmonary embolism. N Engl J Med. 2008;358(10):1037–52.CrossRefPubMedGoogle Scholar
  13. 13.
    Sosland RP, Gupta K. Images in cardiovascular medicine: McConnell’s Sign. Circulation. 2008;118(15):e517–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Kearon C, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–52.CrossRefPubMedGoogle Scholar
  15. 15.
    Dudzinski DM, Piazza G. Multidisciplinary pulmonary embolism response teams. Circulation. 2016;133(1):98–103.CrossRefPubMedGoogle Scholar
  16. 16.
    Meyer G, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370(15):1402–11.CrossRefPubMedGoogle Scholar
  17. 17.
    Konstantinides SV, et al. Management of pulmonary embolism: an update. J Am Coll Cardiol. 2016;67(8):976–90.CrossRefPubMedGoogle Scholar
  18. 18.
    Zamorano JL, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(43):3033–73.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.University of Rochester Medical Center/CardiologyRochesterUSA

Personalised recommendations